Publications by authors named "Sven Taylor"

Claim this Profile
D
Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes.
Hans G F Richter, Gregory M Benson, Denise Blum, Evelyne Chaput, Song Feng, Sven Taylor

Bioorg Med Chem Lett· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective naphthalene H(3) receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs.
Rosa María Rodríguez Sarmiento, Matthias H Nettekoven, Sven Taylor, Jean-Marc Plancher, Hans Richter

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.
Pascale David Pierson, Alec Fettes, Christian Freichel, Silvia Gatti-McArthur, Cornelia Hertel, Sven Taylor

J Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalytic asymmetric deprotonation of phosphine boranes and sulfides as a route to P-stereogenic compounds.
Jonathan J Gammon, Steven J Canipa, Peter O'Brien, Brian Kelly, Sven Taylor

Chem Commun (Camb)· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity.
Leo Alig, Jochem Alsenz, Mirjana Andjelkovic, Stefanie Bendels, Agnès Bénardeau, Sven Taylor

J Med Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalytic asymmetric synthesis of ferrocenes and P-stereogenic bisphosphines.
Cédric Genet, Steven J Canipa, Peter O'Brien, Sven Taylor

J Am Chem Soc· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminothiazole derivatives as neuropeptide Y5 receptor ligands: finding the balance between affinity and physicochemical properties.
Matthias Nettekoven, Wolfgang Guba, Werner Neidhart, Patrizio Mattei, Philippe Pflieger, Sven Taylor

ChemMedChem· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isomeric thiazole derivatives as ligands for the neuropeptide Y5 receptor.
Matthias Nettekoven, Wolfgang Guba, Werner Neidhart, Patrizio Mattei, Philippe Pflieger, Sven Taylor

Bioorg Med Chem Lett· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis